Tesamorelin 10mg / Ipamorelin 3mg

Tesamorelin 10mg + Ipamorelin 3mg

GHRH Analog + Selective GHS • Lyophilized Peptide Blend • Research Use Only

Description: This research‑grade peptide blend combines Tesamorelin, a potent Growth Hormone‑Releasing Hormone (GHRH) analog, with Ipamorelin, a highly selective Growth Hormone Secretagogue (GHS). Together, they are studied for their synergistic ability to enhance endogenous growth hormone (GH) secretion, influence visceral fat metabolism, and support metabolic and cellular‑repair pathways.

Tesamorelin primarily stimulates the pituitary GHRH receptor, while Ipamorelin activates the ghrelin/GHS‑R1a receptor, creating a dual‑pathway GH‑release model that is frequently used in research involving body composition, lipolysis, recovery, and endocrine function.

Specifications

• Peptides:

  • Tesamorelin — 10mg

  • Ipamorelin — 3mg

• Purity: ≥99.8%

• Form: Lyophilized powder

• Quantity: 13mg total peptide content per vial

• Storage:

  • Store at –20°C (–4°F)

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic use

Research Focus Areas

• Growth hormone secretion and dual‑pathway GH‑axis activation

• Visceral adipose tissue and metabolic‑health models

• Body composition, lipolysis, and anti‑aging research

• Muscle recovery, cellular repair, and sleep‑quality studies

• Endocrine function, IGF‑1 signaling, and metabolic regulation

Mechanistic Interest

Tesamorelin (GHRH Analog)

• Stimulates pituitary GHRH receptors to increase natural GH output

• Strongly associated with visceral fat reduction in metabolic research

• Supports IGF‑1 production, anabolic signaling, and lipid metabolism

Ipamorelin (Selective GHS)

• Activates GHS‑R1a to produce clean, controlled GH pulses

• Does not significantly elevate cortisol or prolactin in research models

• Supports sleep‑related GH release, recovery, and cellular repair

Synergistic Research Effects

• Targeted Visceral Fat Reduction The combination enhances GH‑mediated lipolysis, particularly in deep abdominal fat depots, a key focus in metabolic and aging studies.

• Lean Muscle Preservation Dual GH‑pathway activation supports anabolic balance, helping maintain lean mass during fat‑loss research protocols.

• Enhanced Recovery & Sleep Quality Ipamorelin’s influence on slow‑wave sleep and Tesamorelin’s GH‑pulse amplification create a model for studying restorative recovery and cellular repair.

• Metabolic & Cardiovascular Markers Research indicates potential improvements in insulin sensitivity, lipid profiles, and inflammatory markers when visceral fat is reduced.

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.